|TBG Diagnostics Limited -- Australia Stock|| |
0.16 0.00 0.00%
General Manager of Fin.
Mr. Lee Horobin serves as General Manager Finance of Progen Pharmaceuticals Limited since August 23 2012. He served as Company Secretary from March 1 2010 to May 24 2010 and Acting General Manager Finance from March 1 2010 to May 2010. He has commenced with Progen on an interim basis due to an extended period of absence of Mr. Paul Dixon
Executive Since 2012 CPA
61 7 3273 9133 http://www.tbgbio.com
Horobin is a member of CPA Australia and has held company secretarial positions in previous roles.
The company has return on total asset (ROA)
of (47.62) %
which means that it has lost $47.62 on every $100 spent on asset. This is way below average.
TBG Diagnostics Limited, a biotechnology company, focuses on the development, manufacture, and marketing of nucleic acid test kits. TBG Diagnostics Limited (PGL) is traded on Australian Securities Exchange in Australia. It is located in Darra, QLD and employs 10 people.